- Home
- RCS vs LFCR Comparison
RCS vs LFCR Comparison
Compare RCS & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCS
- LFCR
- Stock Information
- Founded
- RCS 1994
- LFCR 1986
- Country
- RCS United States
- LFCR United States
- Employees
- RCS N/A
- LFCR N/A
- Industry
- RCS Investment Managers
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- RCS Finance
- LFCR Health Care
- Exchange
- RCS Nasdaq
- LFCR Nasdaq
- Market Cap
- RCS 329.4M
- LFCR 308.8M
- IPO Year
- RCS N/A
- LFCR N/A
- Fundamental
- Price
- RCS $7.13
- LFCR $7.37
- Analyst Decision
- RCS
- LFCR Buy
- Analyst Count
- RCS 0
- LFCR 4
- Target Price
- RCS N/A
- LFCR $8.00
- AVG Volume (30 Days)
- RCS 141.1K
- LFCR 122.7K
- Earning Date
- RCS 01-01-0001
- LFCR 08-07-2025
- Dividend Yield
- RCS 10.12%
- LFCR N/A
- EPS Growth
- RCS N/A
- LFCR N/A
- EPS
- RCS N/A
- LFCR N/A
- Revenue
- RCS N/A
- LFCR $128,867,000.00
- Revenue This Year
- RCS N/A
- LFCR $4.10
- Revenue Next Year
- RCS N/A
- LFCR $14.29
- P/E Ratio
- RCS N/A
- LFCR N/A
- Revenue Growth
- RCS N/A
- LFCR 0.47
- 52 Week Low
- RCS $4.51
- LFCR $3.68
- 52 Week High
- RCS $6.31
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- RCS 57.05
- LFCR 47.91
- Support Level
- RCS $7.05
- LFCR $7.03
- Resistance Level
- RCS $7.22
- LFCR $7.87
- Average True Range (ATR)
- RCS 0.07
- LFCR 0.40
- MACD
- RCS -0.01
- LFCR 0.01
- Stochastic Oscillator
- RCS 48.89
- LFCR 53.70
About RCS PIMCO Strategic Income Fund Inc.
PIMCO Strategic Income Fund, Inc. operates as a closed-end management investment company. Its primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities. The Fund also seeks capital appreciation to the extent consistent with the objective.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.